BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

838 related articles for article (PubMed ID: 14983490)

  • 1. Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients.
    Volante M; Landolfi S; Chiusa L; Palestini N; Motta M; Codegone A; Torchio B; Papotti MG
    Cancer; 2004 Mar; 100(5):950-7. PubMed ID: 14983490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients.
    Hiltzik D; Carlson DL; Tuttle RM; Chuai S; Ishill N; Shaha A; Shah JP; Singh B; Ghossein RA
    Cancer; 2006 Mar; 106(6):1286-95. PubMed ID: 16470605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aerodigestive tract invasion by well-differentiated thyroid carcinoma: diagnosis, management, prognosis, and biology.
    McCaffrey JC
    Laryngoscope; 2006 Jan; 116(1):1-11. PubMed ID: 16481800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors of insular versus papillary/follicular thyroid carcinoma.
    Falvo L; Catania A; D'Andrea V; Grilli P; D'Ercole C; De Antoni E
    Am Surg; 2004 May; 70(5):461-6. PubMed ID: 15156957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcome of patients with insular carcinoma of the thyroid: the insular histotype is an independent predictor of poor prognosis.
    Pellegriti G; Giuffrida D; Scollo C; Vigneri R; Regalbuto C; Squatrito S; Belfiore A
    Cancer; 2002 Nov; 95(10):2076-85. PubMed ID: 12412160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poorly differentiated thyroid carcinomas: how much poorly differentiated is needed?
    Dettmer M; Schmitt A; Steinert H; Haldemann A; Meili A; Moch H; Komminoth P; Perren A
    Am J Surg Pathol; 2011 Dec; 35(12):1866-72. PubMed ID: 21989341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
    Gemsenjäger E; Heitz PU; Martina B; Schweizer I
    Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical treatment of papillary and follicular thyroid carcinoma.
    Lin JD; Jeng LB; Chao TC; Weng HF; Huang HS
    Int Surg; 1996; 81(1):61-6. PubMed ID: 8803709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in well-differentiated thyroid carcinoma.
    Cushing SL; Palme CE; Audet N; Eski S; Walfish PG; Freeman JL
    Laryngoscope; 2004 Dec; 114(12):2110-5. PubMed ID: 15564829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas.
    Furlan JC; Bedard YC; Rosen IB
    J Am Coll Surg; 2004 Mar; 198(3):341-8. PubMed ID: 14992733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma.
    Rivera M; Ghossein RA; Schoder H; Gomez D; Larson SM; Tuttle RM
    Cancer; 2008 Jul; 113(1):48-56. PubMed ID: 18484584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multivariate study of prognostic factors for differentiated thyroid carcinoma: the significance of histologic subtype.
    Noguchi M; Mizukami Y; Michigishi T; Koyasaki N; Ohta N; Miyazaki I
    Int Surg; 1993; 78(1):10-5. PubMed ID: 8473075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome.
    Haq M; Harmer C
    Clin Endocrinol (Oxf); 2005 Jul; 63(1):87-93. PubMed ID: 15963067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical presentations and outcomes of surgical treatment of follicular variant of the papillary thyroid carcinomas.
    Chang HY; Lin JD; Chou SC; Chao TC; Hsueh C
    Jpn J Clin Oncol; 2006 Nov; 36(11):688-93. PubMed ID: 17000702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of outcome for patients with differentiated and aggressive thyroid carcinoma.
    Marchesi M; Biffoni M; Biancari F; Berni A; Campana FP
    Eur J Surg Suppl; 2003 Jul; (588):46-50. PubMed ID: 15200043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of histologic grading compared with subclassification of papillary thyroid carcinoma.
    Akslen LA; LiVolsi VA
    Cancer; 2000 Apr; 88(8):1902-8. PubMed ID: 10760768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management and outcome of recurrent well-differentiated thyroid carcinoma.
    Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insular carcinoma of the thyroid.
    Cornetta AJ; Burchard AE; Pribitkin EA; O'Reilly RC; Palazzo JP; Keane WM
    Ear Nose Throat J; 2003 May; 82(5):384-6, 388-9. PubMed ID: 12789767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A population-based analysis of survival factors in differentiated and medullary thyroid carcinoma.
    Bhattacharyya N
    Otolaryngol Head Neck Surg; 2003 Jan; 128(1):115-23. PubMed ID: 12574769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.
    Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA
    Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.